The next generation oral selective estrogen receptor degrader (SERD) camizestrant (AZD9833) is active against wild type and mutant estrogen receptor
Christopher Morrow,Larissa Carnevalli,Richard D. Baird,Tim Brier,Carmela Ciardullo,Natalie Cureton,Mandy Lawson,Robert McEwen,Myria Nikolaou,Anne Armstrong,Begona Bermejo, Emiliano Calvo,Eva Ciruelos,Javier Garcia-Corbacho, Erika Hamilton,Jason Incorvati,Peter Kabos,Mafalda Oliveira,Manish R. Patel,Manuel Ruiz-Borrego,Nicholas Turner,Chris Twelves,Christos Vaklavas,Danielle Carroll, Steven Ching, Nevena Cvetesic,Michelle DuPont,Lisa Gibbons,Alastair Mathewson,Rhiannon Maudsley,Pablo Morentin Gutierrez,Avinash Reddy,Jaime Rodriguez-Canales,Susana Ros,Dhivya Sudhan,Andy Sykes, David Whitson,Teresa Klinowska,Justin Lindemann CANCER RESEARCH(2023)
AI 理解论文
溯源树
样例